Skip to main content
. 2018 Jan 22;12(12):1057–1064. doi: 10.1080/15592294.2017.1385685

Figure 1.

Figure 1.

Expression levels of SETDB2 and RIOX2 in cohort #1. A: SETDB2 expression in renal cell tumors (RCTs) and renal normal tissues (RNTs). B: RIOX2 expression in renal cell tumors (RCTs) and renal normal tissues (RNTs). C: SETDB2 expression in benign tumors (oncocytoma) and malignant tumors [renal cell carcinoma (RCCs)]. D: RIOX2 expression in benign tumors (oncocytoma) and malignant tumors (renal cell carcinoma (RCCs)]. E: SETDB2 expression in renal cell tumors subtypes. F: RIOX2 expression in renal cell tumors subtypes. (P values: ****<0.0001; **<0.01; *<0.05).